Follow us on Twitter
twitter icon@FreshPatents

Browse patents:
Next
Prev

Secreted epithelial stromal-1 molecules and uses thereof / Amgen, Inc.




Title: Secreted epithelial stromal-1 molecules and uses thereof.
Abstract: The present invention provides novel Secreted Epithelial Colon Stromal-1 (Secs-1) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing Secs-1 polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides. ...


Browse recent Amgen, Inc. patents


USPTO Applicaton #: #20110151579
Inventors: Anthony J. Polverino, Roland Luethy


The Patent Description & Claims data below is from USPTO Patent Application 20110151579, Secreted epithelial stromal-1 molecules and uses thereof.




← Previous       Next →
Advertise on FreshPatents.com - Rates & Info


You can also Monitor Keywords and Search for tracking patents relating to this Secreted epithelial stromal-1 molecules and uses thereof patent application.

###


Browse recent Amgen, Inc. patents

Keyword Monitor How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Secreted epithelial stromal-1 molecules and uses thereof or other areas of interest.
###


Previous Patent Application:
Method for the detection of breast cancer by determining alcam and/or bcam levels in a patient
Next Patent Application:
Trigger assay for differentiating between rheumatic and non-rheumatic disorders
Industry Class:
Chemistry: analytical and immunological testing
Thank you for viewing the Secreted epithelial stromal-1 molecules and uses thereof patent info.
- - -

Results in 0.03922 seconds


Other interesting Freshpatents.com categories:
QUALCOMM , Monsanto , Yahoo , Corning ,

###

Data source: patent applications published in the public domain by the United States Patent and Trademark Office (USPTO). Information published here is for research/educational purposes only. FreshPatents is not affiliated with the USPTO, assignee companies, inventors, law firms or other assignees. Patent applications, documents and images may contain trademarks of the respective companies/authors. FreshPatents is not responsible for the accuracy, validity or otherwise contents of these public document patent application filings. When possible a complete PDF is provided, however, in some cases the presented document/images is an abstract or sampling of the full patent application for display purposes. FreshPatents.com Terms/Support
-g2-0.2162

66.232.115.224
Browse patents:
Next
Prev

stats Patent Info
Application #
US 20110151579 A1
Publish Date
06/23/2011
Document #
11951797
File Date
12/06/2007
USPTO Class
436501
Other USPTO Classes
5303871, 5303873, 5303879, 5303913, 435331
International Class
/
Drawings
12


Colon Epithelial Prevention

Follow us on Twitter
twitter icon@FreshPatents

Amgen, Inc.


Browse recent Amgen, Inc. patents



Chemistry: Analytical And Immunological Testing   Biospecific Ligand Binding Assay  

Browse patents:
Next
Prev
20110623|20110151579|secreted epithelial stromal-1 molecules and uses thereof|The present invention provides novel Secreted Epithelial Colon Stromal-1 (Secs-1) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing Secs-1 polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of |Amgen-Inc
';